ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Braintree Laboratories, INC.

Official 2024 U.S. DOL Form 5500 summary for Braintree Laboratories, INC. (Sebela Pharmaceuticals INC. 401(k) Plan · EIN 04-2769947 · PN 001): $73.03M net assets, 273 active participants, and $7.72 per $10,000 (7.72 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorBraintree Laboratories, INC.
Filing IdentifierSebela Pharmaceuticals INC. 401(k) Plan · EIN 04-2769947 · PN 001
Plan Category & State401(k) Defined Contribution (MA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$73.03M
Active Participants273
Direct Admin Fee Rate$7.72 per $10,000 (7.72 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderJohn Hancock
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI